Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01798316 · ClinicalTrials.gov registry record · Phase 4
IV Acetaminophen for Postoperative Analgesia
A Phase 4 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 105
- Enrollment target
NCT01798316 is a Phase 4 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 105 participants.
The verdict
NCT01798316, a Phase 4 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 105 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of IV acetaminophen for postoperative pain management after laparoscopic cholecystectomy to determine if its use to supplement standard of care pain management decreases the incidence of post-operative nausea and vomiting.
Interventions
- DRUG Standard of Care
- DRUG IV Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01798316
The ClinicalTrials.gov registry entry for NCT01798316 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT01798316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01798316 about?
NCT01798316 is a clinical study titled "IV Acetaminophen for Postoperative Analgesia". The purpose of this study is to evaluate the use of IV acetaminophen for postoperative pain management after laparoscopic cholecystectomy to determine if its use to supplement standard of care pain management decreases the incidence of post-operative nausea and vomiting.
What is the current status of trial NCT01798316?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 105 participants. The study started on 2013-03. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01798316?
The interventions under investigation include: Standard of Care (DRUG), IV Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT01798316?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.